. .
Français
France
Livres similaires
Autres livres qui pourraient ressembler au livre recherché:
Outils de recherche
s'inscrire

Connectez-vous avec Facebook:

S'inscrire
Mot de passe oublié?


Historique de recherche
Liste pense-bête
Liens vers eurolivre.fr

Partager ce livre sur…
Livre conseillé
Actualités
Conseils d'eurolivre.fr
Publicité
Annonce payée
FILTRE
- 0 Résultats
prix le plus bas: 122,07 €, prix le plus élevé: 175,37 €, prix moyen: 149,88 €
Antiviral Drug Strategies (Methods and Principles in Medicinal Chemistry) - Erik De Clercq, Raimund Mannhold, Hugo Kubinyi, Gerd Folkers
Livre non disponible
(*)
Erik De Clercq, Raimund Mannhold, Hugo Kubinyi, Gerd Folkers:

Antiviral Drug Strategies (Methods and Principles in Medicinal Chemistry) - edition reliée, livre de poche

ISBN: 3527326960

[SR: 4779825], Hardcover, [EAN: 9783527326969], Wiley VCH, Wiley VCH, Book, [PU: Wiley VCH], Wiley VCH, By focusing on general molecular mechanisms of antiviral drugs rather than therapies for individual viruses, this ready reference provides the critical knowledge needed to develop entirely novel therapeutics and to target new viruses. It begins with a general discussion of antiviral strategies, followed by a broad survey of known viral targets, such as reverse transcriptases, proteases, neuraminidases, RNA polymerases, helicases and primases, as well as their known inhibitors. The final section contains several cases studies of recent successful antiviral drug development. Edited by Erik de Clercq, the world authority on small molecule antiviral drugs, who has developed more new antivirals than anyone else., 270945, Pharmacology, 270906, Other Branches of Medicine, 270767, Medical & Healthcare Practitioners, 74, Health, Family & Lifestyle, 1025612, Subjects, 266239, Books, 277912, Biological Sciences, 277972, Animal Sciences, 277913, Biochemistry, 922086, Biological Science, 922084, Biotechnology, 277921, Botany & Plant Sciences, 922194, Ecology, 922094, Education, 922170, Evolution, 277942, Genetics, 277958, Hydrobiology, 922082, Reference, 277948, Taxonomy & Systematics, 57, Science & Nature, 1025612, Subjects, 266239, Books, 278004, Chemistry, 278005, Analytical Chemistry, 277913, Biochemistry, 922214, Education, 922228, Geochemistry, 278012, Inorganic Chemistry, 278015, Laboratory Techniques & Experiments, 278016, Mineralogy, 278017, Organic Chemistry, 278020, Physical Chemistry, 922212, Reference, 57, Science & Nature, 1025612, Subjects, 266239, Books, 278202, Industrial Chemistry, 922268, Chemical, 278115, Engineering & Technology, 57, Science & Nature, 1025612, Subjects, 266239, Books, 564340, Biology, 570626, Animal Sciences, 570694, Biochemistry, 571558, Genetics, 571538, Human Biology, 570680, Microbiology, 571552, Molecular Biology, 570674, Neuroscience, 570610, Plant Sciences, 564334, Scientific, Technical & Medical, 1025612, Subjects, 266239, Books, 564342, Chemistry, 564334, Scientific, Technical & Medical, 1025612, Subjects, 266239, Books

Nouveaux livres Amazon.co.uk
--SuperBookDeals--
Neuware Frais d'envoiEuropa Zone 1: GBP 5,48 pro Produkt.. Usually dispatched within 1-2 business days (EUR 6.75)
Details...
(*) Livre non disponible signifie que le livre est actuellement pas disponible à l'une des plates-formes associées nous recherche.
Antiviral Drug Strategies - Wiley-VCH
Livre non disponible
(*)

Wiley-VCH:

Antiviral Drug Strategies - nouveau livre

ISBN: 9783527326969

ID: a30cb1177198085e1d19f2b0ce272791

Deadly viruses like AIDS, SARS, Ebola and others still cannot be satisfactorily controlled. Finding new antivirals is therefore a prime goal in pharma research. Erik De Clercq is the world authority on small molecule antiviral drugs and has developed more new antivirals than anyone else. New viruses can arise very quickly and, if unchecked, result in major pandemics. Obvious examples being the AIDS and SARS virus. In order to deal with such imminent threats, drug development times need to be cut short. This is only possible by relying on proven strategies and adapting them to the specific features of any new virus or virus variant. By focusing on general molecular mechanisms of antiviral drugs rather than therapies for individual viruses, this ready reference provides the critical knowledge needed to develop entirely novel therapeutics and to target new viruses. It is edited by Erik de Clercq, a world authority on antiviral drug discovery. The volume covers a general discussion of antiviral strategies, followed by a broad survey of known viral targets, such as reverse transcriptases, proteases, neuraminidases, RNA polymerases, helicases, and primases, as well as their known inhibitors. The book also contains several case studies of recent successful antiviral drug development. As a result, medicinal and pharmaceutical chemists, as well as virologists will be able to pinpoint strategies for combating future viral pandemics. Bücher / Fremdsprachige Bücher / Englische Bücher 978-3-527-32696-9, Wiley-VCH

Nouveaux livres Buch.de
Nr. 25607957 Frais d'envoiBücher und alle Bestellungen die ein Buch enthalten sind versandkostenfrei, sonstige Bestellungen innerhalb Deutschland EUR 3,-, ab EUR 20,- kostenlos, Bürobedarf EUR 4,50, kostenlos ab EUR 45,-, Sofort lieferbar, DE. (EUR 0.00)
Details...
(*) Livre non disponible signifie que le livre est actuellement pas disponible à l'une des plates-formes associées nous recherche.
Antiviral Drug Strategies - Herausgegeben von De Clercq, Erik Mannhold, Raimund Kubinyi, Hugo Folkers, Gerd
Livre non disponible
(*)
Herausgegeben von De Clercq, Erik Mannhold, Raimund Kubinyi, Hugo Folkers, Gerd:
Antiviral Drug Strategies - edition reliée, livre de poche

2011

ISBN: 9783527326969

[ED: Hardcover], [PU: Wiley-Vch], New viruses can arise very quickly and, if unchecked, result in major pandemics. Obvious examples being the AIDS and SARS virus. In order to deal with such imminent threats, drug development times need to be cut short. This is only possible by relying on proven strategies and adapting them to the specific features of any new virus or virus variant.By focusing on general molecular mechanisms of antiviral drugs rather than therapies for individual viruses, this ready reference provides the critical knowledge needed to develop entirely novel therapeutics and to target new viruses. It is edited by Erik de Clercq, a world authority on antiviral drug discovery.The volume covers a general discussion of antiviral strategies, followed by a broad survey of known viral targets, such as reverse transcriptases, proteases, neuraminidases, RNA polymerases, helicases, and primases, as well as their known inhibitors. The book also contains several case studies of recent successful antiviral drug development. As a result, medicinal and pharmaceutical chemists, as well as virologists will be able to pinpoint strategies for combating future viral pandemics.1. Auflage. 2011. XX, 406 S. 68 SW-Abb., 39 Farbabb., 28 Tabellen. 240 mmSofort lieferbar, [SC: 0.00]

Nouveaux livres Booklooker.de
buecher.de GmbH & Co. KG
Frais d'envoiVersandkostenfrei, Versand nach Deutschland (EUR 0.00)
Details...
(*) Livre non disponible signifie que le livre est actuellement pas disponible à l'une des plates-formes associées nous recherche.
Antiviral Drug Strategies - Erik De Clercq
Livre non disponible
(*)
Erik De Clercq:
Antiviral Drug Strategies - nouveau livre

ISBN: 9783527326969

[ED: Buch], [PU: Wiley VCH Verlag GmbH], Neuware - New viruses can arise very quickly and, if unchecked, result in major pandemics. Obvious examples being the AIDS and SARS virus. In order to deal with such imminent threats, drug development times need to be cut short. This is only possible by relying on proven strategies and adapting them to the specific features of any new virus or virus variant. By focusing on general molecular mechanisms of antiviral drugs rather than therapies for individual viruses, this ready reference provides the critical knowledge needed to develop entirely novel therapeutics and to target new viruses. It is edited by Erik de Clercq, a world authority on antiviral drug discovery. The volume covers a general discussion of antiviral strategies, followed by a broad survey of known viral targets, such as reverse transcriptases, proteases, neuraminidases, RNA polymerases, helicases, and primases, as well as their known inhibitors. The book also contains several case studies of recent successful antiviral drug development. As a result, medicinal and pharmaceutical chemists, as well as virologists will be able to pinpoint strategies for combating future viral pandemics., [SC: 0.00], Neuware, gewerbliches Angebot, 246x179x49 mm, [GW: 946g]

Nouveaux livres Booklooker.de
Sellonnet GmbH
Frais d'envoiVersandkostenfrei, Versand nach Deutschland (EUR 0.00)
Details...
(*) Livre non disponible signifie que le livre est actuellement pas disponible à l'une des plates-formes associées nous recherche.
Antiviral Drug Strategies, Volume 50 - Mannhold, Raimund; Kubinyi, Hugo; Folkers, Gerd; De Clercq, Erik
Livre non disponible
(*)
Mannhold, Raimund; Kubinyi, Hugo; Folkers, Gerd; De Clercq, Erik:
Antiviral Drug Strategies, Volume 50 - nouveau livre

ISBN: 9783527326969

ID: 693852

New viruses can arise very quickly and, if unchecked, result in major pandemics. Obvious examples being the AIDS and SARS virus. In order to deal with such imminent threats, drug development times need to be cut short. This is only possible by relying on proven strategies and adapting them to the specific features of any new virus or virus variant. By focusing on general molecular mechanisms of antiviral drugs rather than therapies for individual viruses, this ready reference provides the critical knowledge needed to develop entirely novel therapeutics and to target new viruses. It is edited by Erik de Clercq, a world authority on antiviral drug discovery. The volume covers a general discussion of antiviral strategies, followed by a broad survey of known viral targets, such as reverse transcriptases, proteases, neuraminidases, RNA polymerases, helicases, and primases, as well as their known inhibitors. The book also contains several case studies of recent successful antiviral drug development. As a result, medicinal and pharmaceutical chemists, as well as virologists will be able to pinpoint strategies for combating future viral pandemics. Medicine Medicine eBook, Wiley

Nouveaux livres Ebooks.com
Frais d'envoi EUR 0.00
Details...
(*) Livre non disponible signifie que le livre est actuellement pas disponible à l'une des plates-formes associées nous recherche.

< Retour aux résultats de recherche...
Détails sur le livre
Antiviral Drug Strategies
Auteur:

Erik De Clercq

Titre:

Antiviral Drug Strategies

ISBN:

3527326960

By focusing on general molecular mechanisms of antiviral drugs rather than therapies for individual viruses, this ready reference provides the critical knowledge needed to develop entirely novel therapeutics and to target new viruses. It begins with a general discussion of antiviral strategies, followed by a broad survey of known viral targets, such as reverse transcriptases, proteases, neuraminidases, RNA polymerases, helicases and primases, as well as their known inhibitors. The final section contains several cases studies of recent successful antiviral drug development. Edited by Erik de Clercq, the world authority on small molecule antiviral drugs, who has developed more new antivirals than anyone else.

Informations détaillées sur le livre - Antiviral Drug Strategies


EAN (ISBN-13): 9783527326969
ISBN (ISBN-10): 3527326960
Version reliée
Date de parution: 2011
Editeur: Wiley VCH Verlag GmbH
406 Pages
Poids: 0,946 kg
Langue: eng/Englisch

Livre dans la base de données depuis 20.06.2008 09:28:49
Livre trouvé récemment le 02.12.2016 11:01:48
ISBN/EAN: 3527326960

ISBN - Autres types d'écriture:
3-527-32696-0, 978-3-527-32696-9

< Retour aux résultats de recherche...
< pour archiver...
Adjacent Livres